search
Back to results

Mindfulness-based Smoking Cessation Enhanced With Mobile Technology

Primary Purpose

Cigarette Smoking

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness-Based Addiction Treatment
Nicotine Replacement Therapy
Self-help materials
iQuit Mindfully
Sponsored by
Georgia State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cigarette Smoking

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • at least 18 years of age
  • current smoker with history of >3 cigarettes/day (and expired carbon monoxide [CO] >6ppm)
  • motivated to quit within next 30 days
  • valid home address in the greater Atlanta, GA area
  • functioning telephone number
  • can speak, read, and write in English

Exclusion Criteria:

  • contraindication for nicotine patch or nicotine lozenge
  • active substance abuse/dependence
  • current suicidal ideation
  • current use of tobacco cessation medications
  • pregnancy, planning to become pregnant in the next 5 months, or lactation
  • household member enrolled in the study
  • enrolled in previous smoking cessation study based on mindfulness and/or text messaging at Georgia State University

Sites / Locations

  • Georgia State UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Active Comparator

Arm Label

Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully

iQuit Mindfully

Mindfulness-based Addiction Treatment (MBAT)

Usual Care

Arm Description

Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.

Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.

Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.

Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.

Outcomes

Primary Outcome Measures

Number of participants with confirmed smoking abstinence, 8 weeks
Self-report of not smoking in the past 7 days (not even a puff), confirmed by expired carbon monoxide <6 ppm
Number of participants with confirmed smoking abstinence, 12 weeks
Self-report of not smoking in the past 7 days (not even a puff), confirmed by expired carbon monoxide <6 ppm
Number of participants with confirmed smoking abstinence, 24 weeks
Self-report of not smoking in the past 7 days (not even a puff), confirmed by saliva cotinine < 20 ng/ml

Secondary Outcome Measures

Home mindfulness practice (number of days per week)
Self-reported frequency of home mindfulness practice (questionnaire; higher frequency means better outcome)
Dispositional mindfulness (Mindful Attention Awareness Scale [MAAS])
Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; MAAS ranges 1-6)
Dispositional mindfulness (Five Facet Mindfulness Questionnaire-Short Form [FFMQ-SF])
Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; FFMQ-SF ranges 24-120)
Self-compassion (Self-Compassion Scale-Short Form [SCS-SF])
Self-reported self-compassion (questionnaire; higher frequency means better outcome; SCS-SF ranges 1-5)
Stress (Perceived Stress Scale [PSS])
Self-reported stress (questionnaire; lower scores mean better outcome; PSS ranges 0-40)
Emotions (Positive and Negative Affect Schedule [PANAS])
Self-reported positive and negative emotions (questionnaire; lower scores on PANAS-Negative Affect mean better outcome; higher scores on PANAS-Positive Affect mean better outcome; PANAS-Negative Affect and Positive Affect each range 10-50)
Craving and withdrawal (Wisconsin Smoking Withdrawal Scale [WSWS])
Self-reported craving and withdrawal (questionnaire; lower scores mean better outcome; subscale scores for each withdrawal symptom range 0-4)
Nicotine dependence (Brief Wisconsin Dependence Motives Questionnaire [WISDM])
Self-reported nicotine dependence (questionnaire; lower scores mean better outcome; subscale scores for each aspect of dependence range 1-7)
Self-efficacy (Self-Efficacy Scale)
Self-reported self-efficacy to abstain from smoking (questionnaire; higher scores mean better outcome; subscale scores for managing positive affect, negative affect, and craving without smoking range 3-15)
Social support (Multidimensional Scale of Perceived Social Support; higher scores mean better outcome; scores range 1-7)
Self-reported perceived social support (questionnaire)
Program evaluation (questionnaire developed for this study to evaluate participants' perceptions of the helpfulness of intervention components, the extent to which they would recommend the program to others, and suggestions for improvement)
Feedback about interventions and perceived benefits (questionnaire; for quantitative questions, higher scores mean better outcome; for questions about helpfulness and recommending to others, scores range 1-10; for perceived benefits of program, scores range 1-5)

Full Information

First Posted
July 1, 2021
Last Updated
September 11, 2023
Sponsor
Georgia State University
Collaborators
University of Chicago, University of Utah, George Washington University, National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04965181
Brief Title
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
Official Title
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
November 2024 (Anticipated)
Study Completion Date
November 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Georgia State University
Collaborators
University of Chicago, University of Utah, George Washington University, National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to: Aim I: Test the efficacy of a mindfulness-based text messaging program for smoking cessation ("iQuit Mindfully"), both as a standalone intervention and in combination with in-person counseling; and Aim II: Investigate the mechanisms through which mindfulness training impacts smoking cessation.
Detailed Description
This study is a 2 X 2 randomized controlled trial to investigate the effects of the iQuit Mindfully text messaging program, both as a standalone intervention and in combination with in-person counseling (Mindfulness-based Addiction Treatment; MBAT), compared to usual care. Participants will be randomized to one of four groups based on assignment to iQuit Mindfully text messages (yes/no) and in-person MBAT (yes/no): Usual Care (self-help materials + nicotine patch and nicotine lozenge treatment) MBAT (8 weekly virtual MBAT sessions + self-help materials + nicotine patch and nicotine lozenge treatment) iQuit Mindfully (iQuit Mindfully text messages + self-help materials + nicotine patch and nicotine lozenge treatment) MBAT + iQuit Mindfully (8 weekly virtual MBAT sessions + iQuit Mindfully text messages + self-help materials + nicotine patch and nicotine lozenge treatment) All study participants will receive self-help smoking cessation materials, including the "Clearing the Air" booklet developed by the National Cancer Institute (NCI) and a referral to the Tobacco Cessation Quitline (1-800-QUIT-NOW). All study participants will also receive nicotine patches and lozenges. Assessments will occur at baseline and weeks 1, 3, 5, and 8. Follow-up assessments will occur at weeks 12 and 24.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cigarette Smoking

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
485 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
Arm Type
Experimental
Arm Description
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Arm Title
iQuit Mindfully
Arm Type
Experimental
Arm Description
Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Arm Title
Mindfulness-based Addiction Treatment (MBAT)
Arm Type
Experimental
Arm Description
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke >10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness-Based Addiction Treatment
Other Intervention Name(s)
MBAT
Intervention Description
Mindfulness-based Addiction Treatment (MBAT) consists of 8 weekly virtual 2-hour sessions that teach mindfulness and cognitive-behavioral strategies for smoking cessation.
Intervention Type
Drug
Intervention Name(s)
Nicotine Replacement Therapy
Other Intervention Name(s)
Generic Nicotine Patch, Generic Nicotine Lozenge
Intervention Description
Patch therapy (beginning quit day) for participants who smoke >10 cigarettes/day will consist of 4 weeks of 21 mg patches, 2 week of 14 mg patches, and 2 week of 7 mg patches. Patch therapy for participants who smoke less than 10 cigarettes/day will consist of 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Lozenge therapy (beginning quit day) for participants who smoke first cigarette within 30 minutes of waking up will consist of 8 weeks of 4mg lozenges. Lozenge therapy (beginning quit day) for participants who smoke first cigarette 30 minutes of more after they wake up will consist of 8 weeks of 2mg lozenges.
Intervention Type
Behavioral
Intervention Name(s)
Self-help materials
Intervention Description
Self-help materials for smoking cessation are based on the Treating Tobacco Use and Dependence Clinical Practice Guideline (Fiore et al., 2008) and include the "Clearing the Air" booklet developed by the National Cancer Institute (NCI) and a referral to the Tobacco Cessation Quitline (1-800-QUIT-NOW).
Intervention Type
Behavioral
Intervention Name(s)
iQuit Mindfully
Other Intervention Name(s)
Mindfulness-based text messaging for smoking cessation
Intervention Description
iQuit Mindfully involves text messages on each day between treatment sessions. The text messages provide mindfulness and cognitive-behavioral strategies and support for smoking cessation.
Primary Outcome Measure Information:
Title
Number of participants with confirmed smoking abstinence, 8 weeks
Description
Self-report of not smoking in the past 7 days (not even a puff), confirmed by expired carbon monoxide <6 ppm
Time Frame
8 weeks after the start of treatment
Title
Number of participants with confirmed smoking abstinence, 12 weeks
Description
Self-report of not smoking in the past 7 days (not even a puff), confirmed by expired carbon monoxide <6 ppm
Time Frame
12 weeks after the start of treatment
Title
Number of participants with confirmed smoking abstinence, 24 weeks
Description
Self-report of not smoking in the past 7 days (not even a puff), confirmed by saliva cotinine < 20 ng/ml
Time Frame
24 weeks after the start of treatment
Secondary Outcome Measure Information:
Title
Home mindfulness practice (number of days per week)
Description
Self-reported frequency of home mindfulness practice (questionnaire; higher frequency means better outcome)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Dispositional mindfulness (Mindful Attention Awareness Scale [MAAS])
Description
Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; MAAS ranges 1-6)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Dispositional mindfulness (Five Facet Mindfulness Questionnaire-Short Form [FFMQ-SF])
Description
Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; FFMQ-SF ranges 24-120)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Self-compassion (Self-Compassion Scale-Short Form [SCS-SF])
Description
Self-reported self-compassion (questionnaire; higher frequency means better outcome; SCS-SF ranges 1-5)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Stress (Perceived Stress Scale [PSS])
Description
Self-reported stress (questionnaire; lower scores mean better outcome; PSS ranges 0-40)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Emotions (Positive and Negative Affect Schedule [PANAS])
Description
Self-reported positive and negative emotions (questionnaire; lower scores on PANAS-Negative Affect mean better outcome; higher scores on PANAS-Positive Affect mean better outcome; PANAS-Negative Affect and Positive Affect each range 10-50)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Craving and withdrawal (Wisconsin Smoking Withdrawal Scale [WSWS])
Description
Self-reported craving and withdrawal (questionnaire; lower scores mean better outcome; subscale scores for each withdrawal symptom range 0-4)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Nicotine dependence (Brief Wisconsin Dependence Motives Questionnaire [WISDM])
Description
Self-reported nicotine dependence (questionnaire; lower scores mean better outcome; subscale scores for each aspect of dependence range 1-7)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Self-efficacy (Self-Efficacy Scale)
Description
Self-reported self-efficacy to abstain from smoking (questionnaire; higher scores mean better outcome; subscale scores for managing positive affect, negative affect, and craving without smoking range 3-15)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Social support (Multidimensional Scale of Perceived Social Support; higher scores mean better outcome; scores range 1-7)
Description
Self-reported perceived social support (questionnaire)
Time Frame
During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment
Title
Program evaluation (questionnaire developed for this study to evaluate participants' perceptions of the helpfulness of intervention components, the extent to which they would recommend the program to others, and suggestions for improvement)
Description
Feedback about interventions and perceived benefits (questionnaire; for quantitative questions, higher scores mean better outcome; for questions about helpfulness and recommending to others, scores range 1-10; for perceived benefits of program, scores range 1-5)
Time Frame
8 weeks after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: at least 18 years of age current smoker with history of >3 cigarettes/day (and expired carbon monoxide [CO] >6ppm) motivated to quit within next 30 days valid home address in the greater Atlanta, GA area functioning telephone number can speak, read, and write in English Exclusion Criteria: contraindication for nicotine patch or nicotine lozenge active substance abuse/dependence current suicidal ideation current use of tobacco cessation medications pregnancy, planning to become pregnant in the next 5 months, or lactation household member enrolled in the study enrolled in previous smoking cessation study based on mindfulness and/or text messaging at Georgia State University
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Claire A Spears, Ph.D.
Phone
404-413-9335
Email
cspears@gsu.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Josephine Mhende, MPH
Phone
404-413-1465
Email
jojo2@gsu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claire A Spears, Ph.D
Organizational Affiliation
Georgia State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Georgia State University
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30303
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Claire A Spears, Ph.D
Phone
404-413-9335
Email
cspears@gsu.edu
First Name & Middle Initial & Last Name & Degree
Claire A Spears, Ph.D.

12. IPD Sharing Statement

Citations:
PubMed Identifier
27213492
Citation
Vidrine JI, Spears CA, Heppner WL, Reitzel LR, Marcus MT, Cinciripini PM, Waters AJ, Li Y, Nguyen NT, Cao Y, Tindle HA, Fine M, Safranek LV, Wetter DW. Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial. J Consult Clin Psychol. 2016 Sep;84(9):824-838. doi: 10.1037/ccp0000117.
Results Reference
background
PubMed Identifier
35916707
Citation
Spears CA, Mhende J, Hawkins C, Do VV, Hayat MJ, Eriksen MP, Hedeker D, Abroms LC, Wetter DW. Mindfulness-Based Smoking Cessation Delivered Through Telehealth and Text Messaging for Low-Income Smokers: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2022 Aug 1;11(8):e35688. doi: 10.2196/35688.
Results Reference
derived

Learn more about this trial

Mindfulness-based Smoking Cessation Enhanced With Mobile Technology

We'll reach out to this number within 24 hrs